Hanneke Later-NijlandAttorney-at-law at Genome Lawyers
Hanneke is the only lawyer-pharmacist holding a PhD in the Netherlands. She specialises in EU and national (bio)pharma law.
Hanneke holds a PhD in clinical pharmacokinetics and she is also a former Inspector for Clinical Trials and Pharmacovigilance at the Netherlands Inspectorate for Healthcare (“IGJ”). This unique combination of a dual background as well as relevant experience at the competent authority gives her a unique perspective and understanding of the Life Sciences sector.
In her practice, Hanneke advises life sciences and healthcare clients and litigates on a wide range of issues, often with a regulatory focus. Her areas of expertise in the medicinal products field covers the interface between regulatory and patent law, marketing authorisations, market access, reimbursement, clinical trials, GxP compliance, pharmacovigilance, and advertising issues. In addition, she also assists clients with product liability issues, IP and regulatory issues in transactions in the life sciences sector.
She is a lecturer at Leiden University and she publishes frequently on regulatory life sciences issues, such as, new European legislation and the impact of recent judgments in the sector. Furthermore, she is an editor at Jurisprudentie Geneesmiddelenrecht, a magazine published by Sdu covering relevant case law pertaining to pharma law.